We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.78%
2 Healthcare 3.27%
3 Industrials 2.02%
4 Financials 2.02%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAIX
10626
DELISTED
LAIX Inc. American Depositary Shares, each representing fourteen Class A Ordinary Shares
LAIX
$23K ﹤0.01%
1,060
+330
+45% +$7.97K
GALT icon
10627
PUT
Galectin Therapeutics
GALT
$356M
$22K ﹤0.01%
+10,000
New +$26.2K
LEE icon
10628
Lee Enterprises
LEE
$182M
$22K ﹤0.01%
+1,778
New +$17.6K
LGHL
10629
Lion Group Holding
LGHL
$745K
0
TTI icon
10630
CALL
TETRA Technologies
TTI
$1.25B
$22K ﹤0.01%
25,600
+8,800
+52% +$6.04K
XIN
10631
PUT
DELISTED
Xinyuan Real Estate
XIN
$22K ﹤0.01%
1,010
-210
-17% -$4.55K
NTBL
10632
PUT
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$22K ﹤0.01%
+337
New +$16.1K
CCLP
10633
DELISTED
CSI Compressco LP
CCLP
$22K ﹤0.01%
+20,650
New +$19.5K
ALJJ
10634
DELISTED
ALJ Regional Holdings Inc
ALJJ
$22K ﹤0.01%
19,650
+9,037
+85% +$9.57K
BXRX
10635
CALL
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$22K ﹤0.01%
15
-2
-12% -$4.09K
ZNB
10636
Zeta Network Group
ZNB
$2.27M
0
CMMB
10637
Chemomab Therapeutics
CMMB
$13.9M
$21K ﹤0.01%
+190
New +$18.3K
LYG icon
10638
CALL
Lloyds Banking Group
LYG
$90B
$21K ﹤0.01%
+10,600
New +$17.9K
PTN
10639
Palatin Technologies
PTN
$16.8M
$21K ﹤0.01%
25
-54
-68% -$30.9K
PVL
10640
Permianville Royalty Trust
PVL
$57.8M
$21K ﹤0.01%
+29,188
New +$19.2K
REI icon
10641
PUT
Ring Energy
REI
$349M
$21K ﹤0.01%
+31,500
New +$20.8K
TRX icon
10642
PUT
TRX Gold Corp
TRX
$341M
$21K ﹤0.01%
32,100
-2,100
-6% -$1.37K
BMY.RT
10643
PUT
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$21K ﹤0.01%
+102,700
New +$219K
ATOS icon
10644
PUT
Atossa Therapeutics
ATOS
$25.5M
$20K ﹤0.01%
1,400
+487
+53% +$11.3K
DNN icon
10645
CALL
Denison Mines
DNN
$2.95B
$20K ﹤0.01%
31,300
+15,100
+93% +$6.47K
IMNN icon
10646
PUT
Imunon
IMNN
$6.64M
$20K ﹤0.01%
146
+26
+22% +$3.12K
TGB
10647
CALL
Trekor Metals
TGB
$3.08B
$20K ﹤0.01%
15,100
+5,100
+51% +$5.4K
ASXC
10648
PUT
DELISTED
Asensus Surgical, Inc.
ASXC
$20K ﹤0.01%
+31,500
New +$14.4K
RENO
10649
DELISTED
Renovare Environmental, Inc. Common Stock
RENO
$20K ﹤0.01%
+17,735
New +$22.4K
EVOL
10650
DELISTED
Evolving Systems, Inc.
EVOL
$20K ﹤0.01%
+10,038
New +$15.8K

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.